FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Corrects Notice on Pediatric Disease Vouchers

[ Price : $8.95]

Federal Register Notice: FDA corrects a docket number in a notice on fees for using a rare pediatric disease priority review vouch...

Panel to Discuss Hemorrhoid Classification Codes, Heart Care System

[ Price : $8.95]

Federal Register Notice: FDAs Gastroenterology and Urology Devices Panel will meet 11/18-19 to discuss a heart organ care system a...

OCI Probe Leads to Indictment for Product Tampering

[ Price : $8.95]

An investigation by FDAs Office of Criminal Investigations leads to an indictment of Nathan Baum of Greenbush, NY, for tampering w...

FDA Guidance on Integrated Summary of Effectiveness

[ Price : $8.95]

FDA posts a guidance on the Integrated Summary of Effectiveness, which recommends the content of such sections in NDAs and BLAs.

CBER Head Midthun to Retire at Year-end

[ Price : $8.95]

After 22 years of service, CBER director Karen Midthun announces her intention to retire at the end of the year.

Outsourcing Facility Adverse Event Report Guidance

[ Price : $8.95]

FDA issues a guidance with its current thinking on submitting adverse event reports from drug outsourcing facilities.

Firm Selling Unapproved Gertie Marx Needles

[ Price : $8.95]

FDAs Denver District Office warns International Medical Development Corp. that it is manufacturing adulterated and misbranded Gert...

FDA Denies Otsuka Aristada Delay Petition

[ Price : $8.95]

FDA denies an Otsuka petition asking that approval for Alkermes Aristada be delayed or rejected.

Pharmacia & Upjohn Cited After Inspection at Kalamazoo Facility

[ Price : $8.95]

FDA cites a Pharmacia & Upjohn drug manufacturing facility in Kalamazoo, MI for GMP issues following a July inspection.

Implications of Court Decision in Bayer, FTC Case

[ Price : $8.95]

Attorney Jennifer Thomas says companies should ensure that promotional activities are given a thorough medical, legal, and regulat...